Litigation Details for IN RE ASACOL ANTITRUST LITIGATION (D. Mass. 2015)
✉ Email this page to a colleague
IN RE ASACOL ANTITRUST LITIGATION (D. Mass. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-06-22 |
| Court | District Court, D. Massachusetts | Date Terminated | 2019-09-05 |
| Cause | 28:1332 Diversity-(Citizenship) | Assigned To | Denise Jefferson Casper |
| Jury Demand | Both | Referred To | |
| Parties | ALLERGAN, PLC | ||
| Patents | 6,649,180; 6,893,662; 8,580,302 | ||
| Attorneys | Bryan Grant | ||
| Firms | Bryan Grant | ||
| Link to Docket | External link to docket | ||
Details for IN RE ASACOL ANTITRUST LITIGATION (D. Mass. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-06-22 | 1 | Complaint | on Delzicol® is covered by U.S. Patent No. 6,649,180 (“the ‘180 patent”), which expires April 13, 2020…drug sales due to patent expiration has become known as the “patent cliff.” The patent cliff represents…“the ‘170 patent”) and 5,541,171 (“the ‘171 patent”). Both patents expired July 30, 2013. 34…equivalents, and any patents that purportedly protect each drug. 12. Drug patents typically last…which the patent issues and ending 20 years from the date on which the application for the patent was filed | External link to document |
| 2016-07-20 | 110 | Memorandum & ORDER | 11. The Orange Book lists U.S. Patent No. 6,649,180 (“the ’180 patent”) for Delzicol, which expires on…Orange Book lists two patents for Asacol, U.S. Patent Nos. 5,541,170 (“the ’170 patent”) and 5,541,171 (… (“the ’171 patent”). Id. ¶ 67. Both patents expired July 30, 2013. Id. In May 2008, the FDA approved…. ¶ 73. The Orange Book lists two patents for Asacol HD, U.S. Patent Nos. 6,893,662 and 8,580,302. Id…applicable patents are invalid or will not be infringed by the proposed generic drug. Id. If the patent owner | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
